Non-Coding RNAs and Extracellular Vesicles in Cancer Crosstalk: Diagnostic and Therapeutic Implications 2nd Edition

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: 30 November 2025 | Viewed by 194

Special Issue Editors


E-Mail Website
Guest Editor
Institute of Translational Pharmacology (IFT), National Research Council of Italy (CNR), 90146 Palermo, Italy
Interests: extracellular vesicles; exosomes; cell-cell communication; cancer; non-coding RNAs; cancer biomarkers
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Institute of Translational Pharmacology, National Research Council, 90146 Palermo, Italy
Interests: Inflammation; aging; non-coding RNAs; cancer; extracellular vesicles
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Extracellular vesicles (EVs) have been recognized as mediators of intercellular communication that allow horizontal information to be exchanged between cells. Non-coding RNAs (ncRNAs) are selectively packaged into EVs and transferred to proximal and distal target cells, inducing deep phenotypic changes. EVs play a pleiotropic role in cancer and ncRNAs contained in EVs are closely related to varied biological aspects of tumorigenesis. Recently, several findings indicate their key roles in cancer initiation and progression. The eclectic information acquired by evaluating the epigenetic biomarkers contained in EVs is an emerging field in oncology that may help with cancer screening, diagnosis, the identification of tumor subtypes, and the prediction of response to therapy and outcomes.

We invite you contribute a paper to our Special Issue “Non-Coding RNAs and Extracellular Vesicles in Cancer Crosstalk: Diagnostic and Therapeutic Implications”.

This Special Issue will discuss recent findings related to knowledge of biology, epigenetic regulation, early detection, innovations in personalized treatment and therapeutics targeting of ncRNAs, and the involvement of EV-ncRNAs in molecular mechanisms that contribute to cancer development.

Original research articles and reviews are welcome. Research areas may include, but are not limited to, submissions that cover topics relevant to ncRNAs shuttled by EVs, such as mechanism of action, EV engineering with ncRNAs, their functional roles in cancer cells, and clinical studies on the roles of EV-ncRNAs as potential biomarkers in cancer. Studies focusing on their emerging functional roles as targets for cancer treatments are especially welcome.

We look forward to receiving your contributions.

Dr. Simona Taverna
Dr. Giuseppe Cammarata
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • extracellular vesicles
  • exosomes
  • cancer
  • inflammation
  • non-coding RNA
  • microRNAs
  • circular-RNAs
  • PIWI-RNAs
  • lnc-RNAs

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issue

Published Papers

This special issue is now open for submission.
Back to TopTop